Company

About Aurinia Management Team Board of Directors Responsibility

Patients

Aurinia Alliance Resources

Science

Pipeline Lupus Nephritis LUPKYNIS^®AUR200 Scientific Publications

Investors Careers Contact

Pipeline

Product

Indication

Phase 1

Phase 2

Phase 3

U.S. FDA Approval

Lupus nephritis

Autoimmune diseases

Privacy Notice Terms of Use Cookie Settings

©2025 Aurinia Pharmaceuticals Inc. All Rights Reserved.

Navigating away from Aurinia

You are about to leave the Aurinia Pharmaceuticals website. We are not responsible for the content or accuracy of information on any third-party websites nor do we monitor or endorse such websites. If you would like to leave the Aurinia website and visit the third-party website, please select CONTINUE.

Return to Aurinia Continue